[go: up one dir, main page]

AR086557A1 - Soporte de colageno enrollado - Google Patents

Soporte de colageno enrollado

Info

Publication number
AR086557A1
AR086557A1 ARP120101845A ARP120101845A AR086557A1 AR 086557 A1 AR086557 A1 AR 086557A1 AR P120101845 A ARP120101845 A AR P120101845A AR P120101845 A ARP120101845 A AR P120101845A AR 086557 A1 AR086557 A1 AR 086557A1
Authority
AR
Argentina
Prior art keywords
support
compressed collagen
wrapped support
collagen
minimally invasive
Prior art date
Application number
ARP120101845A
Other languages
English (en)
Inventor
Wolfgang Schnhofer
Pernille Dybendal Pedersen
Poul Bertelsen
Henrik Brnder
Ingrid Blanka
Henrik Neuschfer Larsen
Original Assignee
Nycomed Pharma As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nycomed Pharma As filed Critical Nycomed Pharma As
Publication of AR086557A1 publication Critical patent/AR086557A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/02—Adhesive bandages or dressings
    • A61F13/0276—Apparatus or processes for manufacturing adhesive dressings or bandages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/438—The ring being spiro-condensed with carbocyclic or heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A61K38/363—Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4833—Thrombin (3.4.21.5)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/043—Mixtures of macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/041—Mixtures of macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods
    • A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Surgery (AREA)
  • Hematology (AREA)
  • Manufacturing & Machinery (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Inorganic Chemistry (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Materials For Medical Uses (AREA)
  • Peptides Or Proteins (AREA)
  • Prostheses (AREA)

Abstract

Un proceso para la preparación de un soporte de colágeno comprimido enrollado y un proceso para desenrollar dicho soporte de colágeno comprimido enrollado. Dicho soporte de colágeno comprimido enrollado está listo para su uso en una cirugía mínimamente invasiva. La presente también se relaciona con un soporte de colágeno comprimido enrollado para su uso en la prevención o el tratamiento de una lesión asociada con la realización de una cirugía mínimamente invasiva.
ARP120101845A 2011-05-24 2012-05-24 Soporte de colageno enrollado AR086557A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP11167379 2011-05-24

Publications (1)

Publication Number Publication Date
AR086557A1 true AR086557A1 (es) 2014-01-08

Family

ID=44692373

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP120101845A AR086557A1 (es) 2011-05-24 2012-05-24 Soporte de colageno enrollado

Country Status (38)

Country Link
US (2) US9814686B2 (es)
EP (2) EP3243489B8 (es)
JP (1) JP6025824B2 (es)
KR (1) KR101833035B1 (es)
CN (1) CN103702645B (es)
AP (1) AP2013007327A0 (es)
AR (1) AR086557A1 (es)
AU (1) AU2012261339B2 (es)
BR (1) BR112013029709B1 (es)
CA (1) CA2837117C (es)
CL (1) CL2013003274A1 (es)
CO (1) CO6862131A2 (es)
CY (1) CY1119313T1 (es)
DK (2) DK2713972T3 (es)
EA (1) EA028878B1 (es)
ES (2) ES2642151T3 (es)
GE (1) GEP201706715B (es)
HR (1) HRP20171424T1 (es)
HU (1) HUE032689T4 (es)
IL (1) IL229446A (es)
LT (1) LT2713972T (es)
MD (1) MD4471C1 (es)
ME (1) ME02830B (es)
MX (1) MX355925B (es)
MY (1) MY185054A (es)
PE (1) PE20141037A1 (es)
PH (1) PH12013502432A1 (es)
PL (2) PL3243489T3 (es)
PT (1) PT2713972T (es)
RS (1) RS56367B1 (es)
SA (1) SA112330549B1 (es)
SI (1) SI2713972T1 (es)
TN (1) TN2013000391A1 (es)
TW (1) TWI552774B (es)
UA (1) UA113959C2 (es)
UY (1) UY34096A (es)
WO (1) WO2012159635A1 (es)
ZA (1) ZA201307060B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY185054A (en) 2011-05-24 2021-04-30 Takeda As Rolled collagen carrier
KR102162416B1 (ko) 2012-05-24 2020-10-07 다케다 에이에스 코일링된 콜라겐 캐리어를 제공하기 위한 장치 및 방법
KR102107257B1 (ko) 2012-05-24 2020-05-07 다케다 에이에스 포장재
GB2543307B (en) * 2015-10-14 2020-12-09 Selentus Science Ltd Haemostatic device
WO2018051205A1 (es) * 2016-09-16 2018-03-22 Universidad De Los Andes Tapón hemostático de matriz extracelular para biopsias percutáneas y aparato para su fabricación
MD1169Z (ro) * 2016-12-06 2018-02-28 Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова Metodă de obţinere a spongiei de colagen
TWI797407B (zh) * 2018-12-28 2023-04-01 國立成功大學 生物支架及其製備方法
DE102019213178A1 (de) * 2019-08-30 2021-03-04 Resorba Medical Gmbh Polymerfolie und Polymertasche zur Aufnahme eines zu implantierenden medizinisch-technischen Produkts
CN111839637B (zh) * 2020-09-04 2022-05-10 青岛市市北区蓝天心理研究所 一种妇科伤口缝合辅助装置
EP4240435B1 (en) * 2020-11-05 2024-09-25 Datum Dental Ltd. Multi-layered collagen structure
CN117919517A (zh) * 2024-01-26 2024-04-26 陕西省眼科研究所 去细胞角膜基质板层组织联合生物胶泪道栓及其制备方法

Family Cites Families (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE404337A (es) 1933-02-11 1900-01-01
GB423017A (en) 1934-05-24 1935-01-23 Koninklijke Pharma Fab Nv A process and apparatus for the manufacture of threads, strings, bands, films and the like from animal fibres
GB487258A (en) 1936-02-07 1938-06-17 Koninklijke Pharma Fab Nv Tampons and other porous articles, such as sheaths and bandages, and a process for producing same
DE3105624A1 (de) * 1981-02-16 1982-09-02 Hormon-Chemie München GmbH, 8000 München Material zum abdichten und heilen von wunden
US5147387A (en) 1990-10-10 1992-09-15 W. L. Gore & Associates, Inc. Process of implanting a prosthetic sheet repair material
US5290310A (en) 1991-10-30 1994-03-01 Howmedica, Inc. Hemostatic implant introducer
RU2018540C1 (ru) 1992-11-23 1994-08-30 Товарищество с ограниченной ответственностью Фирма "Копримекс" Способ получения коллагенсодержащего материала
US5334216A (en) 1992-12-10 1994-08-02 Howmedica Inc. Hemostatic plug
US5942278A (en) 1993-03-31 1999-08-24 Nycomed Arzneimittel Gmbh Process for the production of a material for sealing and healing wounds
AT410754B (de) * 1993-03-31 2003-07-25 Nycomed Austria Gmbh Vorrichtung zum gleichmässigen auftragen einer suspension auf einen kollagenträger
US6177126B1 (en) 1993-03-31 2001-01-23 Nycomed Arzneimittel Gmbh Process for the production of a material for sealing and healing wounds
AT402683B (de) 1995-05-16 1997-07-25 Hafslund Nycomed Pharma Gerät für endoskopische oder laparoskopische applikation von chirurgischem material
CZ292389B6 (cs) 1995-12-13 2003-09-17 Nycomed Austria Gmbh Nástroj pro aplikaci chirurgického materiálu
DE19546435A1 (de) 1995-12-13 1997-06-19 Nycomed Arzneimittel Gmbh Vorrichtung zum Einbringen von wundheilendem oder wundversiegelnden Material in den Körper
RU2118176C1 (ru) 1996-09-27 1998-08-27 Истранов Леонид Прокофьевич Способ получения коллагеновых пластинок
JP2001516261A (ja) 1997-03-20 2001-09-25 フォーカル・インコーポレーテッド 生物分解性の組織開創器
FR2777284B1 (fr) * 1998-04-10 2000-05-26 Hamza Mansour Procede de sterilisation d'un collagene natif en milieu liquide, collagene natif sterile obtenu, compositions le contenant et applications
DE19922078A1 (de) 1999-05-15 2000-11-23 Weitzel Kage Doris Gewebekonstrukt für die Transplantationschirurgie
BRPI0206708B8 (pt) * 2001-01-25 2021-06-22 Nycomed Pharma As composição sólida, composição para hemostasia, vedação de tecido e colagem de tecido, e, usos de um veículo de colágeno
US7098315B2 (en) * 2001-01-25 2006-08-29 Nycomed Pharma As Method of preparing a collagen sponge, a device for extracting a part of a collagen foam, and an elongated collagen sponge
US20020164322A1 (en) 2001-01-25 2002-11-07 Alfred Schaufler Suspension comprising fibrinogen, thrombin and alcohol, a method for preparing such a suspension, a method for coating a carrier with such a suspension, a method of drying a coating of a carrier, and a coated collagen sponge
US7052713B2 (en) 2001-02-13 2006-05-30 Nycomed Pharma As Carrier with solid fibrinogen and solid thrombin
CZ300918B6 (cs) 2001-04-13 2009-09-09 I-Flow Corporation Souprava pro regulaci bolesti pro provádení procedury nervové blokády
US8465516B2 (en) * 2001-07-26 2013-06-18 Oregon Health Science University Bodily lumen closure apparatus and method
EP1408847B1 (en) 2001-07-26 2005-05-04 Oregon Health Sciences University Vessel closure member and delivery apparatus
TWI324524B (en) * 2002-01-25 2010-05-11 Nycomed Pharma As Carrier with solid fibrinogen and solid thrombin
WO2003065877A2 (en) 2002-02-04 2003-08-14 Damage Control Surgical Technologies, Inc. Method and apparatus for improved hemostasis and damage control operations
US7166133B2 (en) 2002-06-13 2007-01-23 Kensey Nash Corporation Devices and methods for treating defects in the tissue of a living being
JP4581318B2 (ja) 2002-08-09 2010-11-17 ニプロ株式会社 生分解性筒状体およびそれを用いた生体組織または器官再生器具
JP4168740B2 (ja) 2002-12-12 2008-10-22 ニプロ株式会社 コラーゲン製人工血管
US7329792B2 (en) 2003-02-04 2008-02-12 Damage Control Surgical Technologies, Inc. Method and apparatus for hemostasis
RU2235539C1 (ru) 2003-04-25 2004-09-10 Филатов Владимир Николаевич Способ получения порошкообразного материала для остановки кровотечений
CN1251655C (zh) * 2003-06-13 2006-04-19 常春荣 快速生物封闭止血装置及其制造工艺
US20050208095A1 (en) 2003-11-20 2005-09-22 Angiotech International Ag Polymer compositions and methods for their use
CN2705167Y (zh) * 2004-02-20 2005-06-22 佟刚 胶原贴敷料
WO2005123171A2 (en) * 2004-06-09 2005-12-29 Stout Medical Group Lp Three-dimensional coils for treatment of vascular aneurysms
GB0415080D0 (en) 2004-07-05 2004-08-04 Ucl Biomedica Plc Methods for preparing tissue equivalent implants and products thereof
AU2005295365B2 (en) 2004-10-20 2010-08-05 Ethicon, Inc. Absorbable hemostat
JP4995811B2 (ja) 2005-04-29 2012-08-08 クック・バイオテック・インコーポレーテッド 瘻治療用容積式移植片並びに関連の方法及びシステム
JP4765602B2 (ja) 2005-12-14 2011-09-07 ニプロ株式会社 再生医療用器具の包装体及び再生医療用器具用の処理方法
US8795709B2 (en) 2006-03-29 2014-08-05 Incept Llc Superabsorbent, freeze dried hydrogels for medical applications
US20080033332A1 (en) * 2006-08-04 2008-02-07 Macphee Martin Solid dressing for treating wounded tissue
US8299316B2 (en) * 2007-12-18 2012-10-30 Ethicon, Inc. Hemostatic device
KR101541702B1 (ko) 2008-03-03 2015-08-04 옴릭스 바이오파머슈티컬스 리미티드 활성 성분을 포함하는 젤라틴 스펀지, 이의 제조 방법 및 용도
MX338212B (es) 2008-04-11 2016-04-07 Univ Virginia Commonwealth Fibras de dextran electrohiladas y dispositivos formados de las mismas.
EP2268326B1 (en) 2008-04-30 2016-11-23 Ethicon, Inc Tissue engineered blood vessel
CA2723172A1 (en) 2008-05-02 2009-11-05 Providence Health System-Oregon D/B/A Providence St. Vincent Medical Cen Ter Wound dressing devices and methods
JP5157689B2 (ja) * 2008-07-07 2013-03-06 ニプロ株式会社 内視鏡下手術用デバイス
US9061464B2 (en) 2008-09-03 2015-06-23 Collagen Matrix, Inc. Re-rollable wrapping implant
WO2010053737A1 (en) 2008-10-29 2010-05-14 Wilson-Cook Medical, Inc. Endoscopic sheet delivery
CN201342005Y (zh) * 2009-02-02 2009-11-11 沂南县天成生物制品有限公司 一种壳聚糖复合生物止血膜
US8926552B2 (en) 2009-08-12 2015-01-06 Medtronic, Inc. Particle delivery
MY185054A (en) 2011-05-24 2021-04-30 Takeda As Rolled collagen carrier

Also Published As

Publication number Publication date
KR101833035B1 (ko) 2018-02-27
DK3243489T3 (da) 2021-05-10
JP2014519897A (ja) 2014-08-21
DK2713972T3 (en) 2017-10-09
RS56367B1 (sr) 2017-12-29
CA2837117A1 (en) 2012-11-29
MD4471B1 (ro) 2017-03-31
EP3243489B1 (en) 2021-02-17
LT2713972T (lt) 2017-09-11
KR20140033425A (ko) 2014-03-18
AU2012261339A1 (en) 2013-03-07
EP2713972A1 (en) 2014-04-09
MD20130097A2 (ro) 2014-06-30
TN2013000391A1 (en) 2015-01-20
MD4471C1 (ro) 2017-10-31
EP2713972B9 (en) 2017-11-15
AU2012261339B2 (en) 2014-06-12
UY34096A (es) 2018-06-29
EP2713972B1 (en) 2017-06-28
HUE032689T4 (en) 2017-11-28
TWI552774B (zh) 2016-10-11
US20180085322A1 (en) 2018-03-29
IL229446A0 (en) 2014-01-30
JP6025824B2 (ja) 2016-11-16
CL2013003274A1 (es) 2014-06-20
PL2713972T3 (pl) 2017-11-30
EP3243489B8 (en) 2022-03-23
US20140072612A1 (en) 2014-03-13
CY1119313T1 (el) 2018-02-14
IL229446A (en) 2017-06-29
PE20141037A1 (es) 2014-08-27
US9814686B2 (en) 2017-11-14
ZA201307060B (en) 2014-05-28
UA113959C2 (xx) 2017-04-10
CN103702645B (zh) 2015-10-21
MX355925B (es) 2018-05-04
CO6862131A2 (es) 2014-02-10
MX2013013435A (es) 2014-07-09
EA201391716A1 (ru) 2014-03-31
CA2837117C (en) 2017-08-29
BR112013029709B1 (pt) 2021-07-20
ES2642151T9 (es) 2018-01-08
PT2713972T (pt) 2017-09-22
SI2713972T1 (sl) 2017-10-30
TW201300143A (zh) 2013-01-01
AP2013007327A0 (en) 2013-12-31
GEP201706715B (en) 2017-08-10
PL3243489T3 (pl) 2021-11-02
EA028878B1 (ru) 2018-01-31
PH12013502432A1 (en) 2014-01-13
WO2012159635A1 (en) 2012-11-29
ES2871064T3 (es) 2021-10-28
NZ615820A (en) 2015-10-30
CN103702645A (zh) 2014-04-02
HRP20171424T1 (hr) 2017-11-03
ES2642151T3 (es) 2017-11-15
ME02830B (me) 2018-01-20
MY185054A (en) 2021-04-30
SA112330549B1 (ar) 2016-03-02
BR112013029709A2 (pt) 2020-12-15
HUE032689T2 (en) 2017-10-30
EP3243489A1 (en) 2017-11-15
US10532032B2 (en) 2020-01-14

Similar Documents

Publication Publication Date Title
AR086557A1 (es) Soporte de colageno enrollado
HUS2500031I1 (hu) Humánellenanyag-farmakon konjugátum szöveti faktor ellen
CO6811867A2 (es) Cannabinoides para uso en el tratamiento del dolor neuropático
ES2661582T3 (es) Efecto antiinflamatorio de la celulosa microfibrilada
LTC2523731I2 (lt) Antinksčių hormoną modifikuojančio agento panaudojimas
WO2011075731A3 (en) Tissue expanders and methods of use
CL2014000630A1 (es) Una composicion que comprende 1) un compuesto derivado de nucleosido denominado como compuesto 10 y 2) un compuesto derivado de acido 5-tiofeno-2-carboxilico denominado como compuesto 5 o un compuesto derivado del ester metilico del acido carbamico denominado como compuesto 6; y su uso para el tratamiento profilactico o terapeutico de una infeccion por vhc.
MX2020010607A (es) Compuestos y metodos para inhibir el transporte de fosfato.
PL2515812T3 (pl) Zastosowanie poliuretanowego tworzywa piankowego jako opatrunku na rany w terapii podciśnieniowej
CO6900138A2 (es) Nuevos sulfóxidos de piperidino-dihidrotienopirimidina y su uso para tratar epoc y asma
CO7160029A2 (es) Compuestos de heterociclilo como inhibidores de mek
BR112012029746A2 (pt) composição para tratamento da pele, método para fornecer um efeito microbicida para pele e uso de uma combinação
EP3079604B8 (en) Apparatus for attaching tissue to bone, including the provision and use of a novel knotless suture anchor system
HUE049217T2 (hu) Szövetkárosodás és fibrózis enyhítése LTBP4 elleni ellenanyaggal
CL2013001579A1 (es) Uso de una composicion farmaceutica que comprende un compuesto agonista ep4 para tratar marcas de la piel tales como heridas superficiales, cicatrices o arrugas.
CO6731092A2 (es) Nueva forma de administración de inhibidor de encefalinasa
EP2556820A4 (en) COMPOSITION CONTAINING PDE5 INHIBITOR FOR MITIGATION OF SKIN WRINKLES
CO7240418A2 (es) Apósito con una liberación prolongada de agentes activos
PL2549995T3 (pl) Zastosowanie anatabiny w leczeniu stanów zapalnych i metody syntezy anatabiny
PE20150167A1 (es) (r)-nifuratel, su uso para el tratamiento de las infecciones y sintesis de (r) y (s)-nifuratel
ECSP12012102A (es) Proceso para producir un extracto de alérgenos
PL2614824T3 (pl) Pochodna triazolowa do stosowania w leczeniu bólu neuropatycznego i fibromialgii
CL2014002191A1 (es) Uso de inhibidores de succinato deshidrogenasa para controlar enfermedades del leño en la vid.
BR112013013276A2 (pt) processo para produzir couro, couro, formulação aquosa, e uso da mesma
CR20140526A (es) Dronedarona para uso en la leishmaniosis, formulaciones y asociaciones para uso en la leishmaniosis

Legal Events

Date Code Title Description
FG Grant, registration